BiomX gets NYSE American approval for plan to regain listing compliance by Sept. 25, 2027

BiomX Inc.

BiomX Inc.

PHGE

0.00
  • BiomX won NYSE American acceptance of its plan to regain listing compliance, securing a plan period through Sept. 25, 2027.
  • NYSE American cited non-compliance with Sections 1003(a)(i)-(iii) tied to a stockholders’ deficit of $(1.302 million) at Dec. 31, 2025.
  • Shares remain listed during the plan period, subject to periodic exchange reviews and continued progress under the plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BiomX Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606120900PRIMZONEFULLFEED9746097) on June 12, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.